JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB261869

人SLC2A1 (Glucose Transporter GLUT1) knockout A549 cell line

Human SLC2A1 (Glucose Transporter GLUT1) knockout A549 cell line

Be the first to review this product! Submit a review

|

(1 Publication)

SLC2A1 KO cell line available to order. KO validated by Next Generation Sequencing. Free of charge wild type control available. Knockout achieved by CRISPR/Cas9 X = 1 bp insertion Frameshift = 100%. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.

查看别名

SLC2A1, GLUT1, HepG2 glucose transporter, GLUT-1

3 Images
Western blot - Human SLC2A1 (Glucose Transporter GLUT1) knockout A549 cell line (AB261869)
  • WB

Supplier Data

Western blot - Human SLC2A1 (Glucose Transporter GLUT1) knockout A549 cell line (AB261869)

Lanes 1 - 2 : Merged signal (red and green). Green - ab196357 observed at 54 kDa. Red - loading control, ab8245, observed at 37 kDa.

ab196357 was shown to recognize in wild-type A549 cells as signal was lost at the expected MW in SLC2A1 knockout cells. Additional cross-reactive bands were observed in the wild-type and knockout cells. Wild-type and SLC2A1 knockout samples were subjected to SDS-PAGE. ab196357 and ab8245 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1 μg/ml and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Glucose Transporter GLUT1 antibody [EPR3915] (<a href='/products/primary-antibodies/glucose-transporter-glut1-antibody-epr3915-ab115730'>ab115730</a>) at 1 µg/mL

Lane 1:

Wild-type A549 whole cell lysate at 20 µg

Lane 2:

Western blot - Human SLC2A1 (Glucose Transporter GLUT1) knockout A549 cell lysate (<a href='/products/cell-lysates/human-slc2a1-glucose-transporter-glut1-knockout-a549-cell-lysate-ab261678'>ab261678</a>) at 20 µg

Predicted band size: 54 kDa

false

Next Generation Sequencing - Human SLC2A1 (Glucose Transporter GLUT1) knockout A549 cell line (AB261869)
  • NGS

Supplier Data

Next Generation Sequencing - Human SLC2A1 (Glucose Transporter GLUT1) knockout A549 cell line (AB261869)

1 bp insertion after Gln24 of the WT protein

Next Generation Sequencing - Human SLC2A1 (Glucose Transporter GLUT1) knockout A549 cell line (AB261869)
  • NGS

Lab

Next Generation Sequencing - Human SLC2A1 (Glucose Transporter GLUT1) knockout A549 cell line (AB261869)

X =1 bp insertion

关键信息

细胞类型

A549

种属

Human

组织

Lung

形式

Liquid

form

敲除验证

Next Generation Sequencing

突变描述

Knockout achieved by CRISPR/Cas9 X = 1 bp insertion Frameshift = 100%

疾病

Carcinoma

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "NGS": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

产品详情

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

规格

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab261869-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab259777 Human wild-type A549 cell line", "number":"AB261869-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab261869 Human SLC2A1 (Glucose Transporter GLUT1) knockout A549 cell line", "number":"AB261869-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab261869-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab261869 Human SLC2A1 (Glucose Transporter GLUT1) knockout A549 cell line", "number":"AB261869-CMP01", "productcode":"" } ] } } }

性能和储存信息

基因名称
SLC2A1
基因编辑类型
Knockout
基因编辑方法
CRISPR technology
敲除验证
Next Generation Sequencing
运输条件
Dry Ice
推荐的短期储存条件
-196°C
推荐的长期储存条件
-196°C

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

The Glucose Transporter GLUT1 also known as SLC2A1 is an important protein responsible for the transport of glucose across cell membranes. The GLUT1 transporter has a molecular weight of approximately 55 kDa. This protein is highly expressed in erythrocytes endothelial cells lining blood vessels and in the blood-brain barrier. Its primary role is to facilitate the basal glucose uptake necessary for cellular metabolism particularly in tissues where glucose is a critical energy source.
Biological function summary

This glucose transporter plays a significant role in maintaining glucose homeostasis in the human body. GLUT1 functions independently and not as part of a complex. It ensures that glucose is available to cells with high metabolic demands including the brain and red blood cells where it remains important for survival and function. Its expression level can be influenced by various factors including hypoxia and insulin.

Pathways

GLUT1 is involved in the glycolysis and hypoxia-related pathways. It supports the glycolytic pathway by ensuring a sufficient supply of glucose to the cells which is then metabolized to produce ATP. Additionally during hypoxic conditions GLUT1 expression can increase aligning with proteins like HIF-1α which helps cells adapt by modifying their metabolism. This coordinated regulation permits cells to adjust their energy systems according to the oxygen availability.

GLUT1 is implicated in glucose transporter type 1 deficiency syndrome (GLUT1 DS) and various forms of cancer. GLUT1 DS results from inadequate glucose transport into the brain presenting neurological symptoms due to energy deficiency. In cancer overexpression of GLUT1 links to increased glucose uptake and tumor growth a condition known to involve proteins like hexokinase. These associations underline GLUT1's contribution to both genetic defects and metabolic shifts in cancerous tissues.

质量控制

STR 分析

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

细胞培养

生物安全等级

EU: 1 US: 1

贴壁/悬浮

Adherent

性别

Male

初始处理指南

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability. <p>1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.<br>2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.<br>3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.<br>4. Incubate the culture at 37°C incubator with 5% CO<sub>2</sub>. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.<br>5. Once confluent passage into an appropriate flask at a density of 2x10<sup>4</sup> cells/cm<sup>2</sup>. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.</p>

传代培养指南
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
  • Do not allow the cell density to exceed 7x104 cells/cm2.
培养基

F-12K + 10% FBS

低温储藏试剂

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

产品实验方案

文献 (1)

Recent publications for all applications. Explore the full list and refine your search

Open life sciences 18:20220697 PubMed37941780

2023

Knockdown of SETD5 inhibited glycolysis and tumor growth in gastric cancer cells by down-regulating Akt signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Shi,Litao Yu,Changhong Zhu,Haiyan Zhong
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com